Egholm Michael
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Egholm Michael. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| LAB | President & CEO | Tax Withholding | 63,529 | $1.28 | $81,317 | Nov 20, 2025 |
| LAB | President & CEO | Tax Withholding | 54,919 | $1.27 | $69,747 | Aug 20, 2025 |
| LAB | President & CEO | Award / Grant | 3,000,000 | — | — | Aug 1, 2025 |
| LAB | President & CEO | Tax Withholding | 9,906 | $1.09 | $10,798 | May 28, 2025 |
| LAB | President & CEO | Sale | 5,473 | $0.94 | $5,145 | May 23, 2025 |
| LAB | President & CEO | Sale | 5,116 | $1.00 | $5,116 | May 22, 2025 |
| LAB | President & CEO | Sale | 4,719 | $1.03 | $4,861 | May 20, 2025 |
| LAB | President & CEO | Tax Withholding | 57,676 | $1.07 | $61,713 | Apr 4, 2025 |
| LAB | President & CEO | Award / Grant | 1,188,333 | — | — | Mar 21, 2025 |
| LAB | President & CEO | Tax Withholding | 31,031 | $1.39 | $43,133 | Feb 20, 2025 |
| LAB | President & CEO | Tax Withholding | 28,795 | $1.51 | $43,480 | Nov 20, 2024 |
| LAB | President & CEO | Tax Withholding | 29,093 | $1.91 | $55,568 | Aug 20, 2024 |
| LAB | President & CEO | Award / Grant | 1,000,000 | — | — | May 20, 2024 |
| LAB | President & CEO | Tax Withholding | 102,564 | $2.71 | $277,948 | Apr 8, 2024 |
| LAB | President & CEO | Option Exercise | 196,512 | — | — | Jan 5, 2024 |
| LAB | President & CEO | Option Exercise | 196,512 | — | — | Apr 4, 2023 |
| 0000075829 | President, BioPharmaceuticals | Disposition | 12,822 | — | — | Aug 31, 2015 |
| 0000075829 | President, BioPharmaceuticals | Tax Withholding | 8,805 | $126.67 | $1,115,329 | Aug 13, 2015 |
| 0000075829 | President, BioPharmaceuticals | Option Exercise | 1,595 | $125.52 | $200,246 | Jul 13, 2015 |
| 0000075829 | President, BioPharmaceuticals | Sale | 8,147 | $124.55 | $1,014,709 | Jun 29, 2015 |
| 0000075829 | President, BioPharmaceuticals | Sale | 4,815 | $100.38 | $483,330 | Dec 22, 2014 |
| 0000075829 | Chief Technology Officer | Sale | 1,300 | $82.04 | $106,652 | Jul 14, 2014 |
| 0000075829 | Chief Technology Officer | Sale | 707 | $67.82 | $47,949 | Mar 7, 2013 |
| 0000075829 | Chief Technology Officer | Tax Withholding | 1,813 | $68.51 | $124,209 | Feb 4, 2013 |
| 0000075829 | Chief Technology Officer | Sale | 845 | $64.20 | $54,249 | Jan 10, 2013 |